PCRX- Pacira Biosciences, Inc.

Name: Pacira Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Lee Frank D.	399.0K	$9.39M	-
Other	Slonin Jonathan	218.9K	$5.15M	-
Other	Williams Kristen	167.1K	$3.93M	-10,259
CFO	Cross Shawn	118.3K	$2.78M	-
VP	Riker Lauren	62.3K	$1.47M	-6,115

Activity

Buys and sells only

Transactions

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 10, 2019	Riker Lauren Bullaro76	Vice President, Finance	Sell	2,126	$44.28	$94,139.28	-17.5%
Jun 5, 2019	Scranton Richard	Chief Scientific Officer	Sell	9,040	$43.10	$389,620.66	-17.0%
Jun 4, 2019	Hastings Paul J77	Director	Sell	782	$42.66	$33,360.12	-22.2%
Jun 4, 2019	Winston Roy68	Chief Clinical Officer	Sell	722	$42.91	$30,981.02	-4.2%
Jun 4, 2019	Williams Kristen Marie76	CAO And General Counsel	Sell	2,529	$42.91	$108,519.39	-11.3%
Jun 4, 2019	Stack David M67	CEO And Chairman	Sell	12,385	$42.91	$531,440.35	-9.2%
Jun 4, 2019	Riker Lauren Bullaro76	Vice President, Finance	Sell	967	$42.91	$41,493.97	-8.6%
Jun 4, 2019	Reinhart Charles A. III64	Chief Financial Officer	Sell	1,106	$42.91	$47,458.46	-8.5%
Jun 4, 2019	McLoughlin Dennis64	Chief Commercial Officer	Sell	1,099	$42.91	$47,158.09	-7.4%
Jun 4, 2019	Laranjeira Charles Anthony61	SVP, Technical Operations	Sell	430	$42.91	$18,451.30	-7.4%

← PrevPage 16Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC